Hopp til hovedinnhold

Helicobacter pylori

Helicobacter pylori (Hp) er en bakterie som kan forekomme i slimhinnen i magesekken. Infeksjon med Hp er den viktigste årsaken til magesårsykdommen.

Sist revidert:

QR
Del pasientinformasjon

Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon

https://nhi.no/sykdommer/magetarm/magesekk/helicobacter-pylori/ 

Hva er Helicobacter pylori?

Magesårsbakterien

Påvisning av Hp

Magesår

Behandling

Vil du vite mer?

Kilder

Referanser

Dette dokumentet er basert på det profesjonelle dokumentet Helicobacter pylori. Referanselisten for dette dokumentet vises nedenfor.

  1. Smittervernveilederen. Helicobacter pylori-infeksjon - veileder for helsepersonell. Folkehelseinstituttet, sist oppdatert 30.01.2018. fhi.no 
  2. Lamont JT. Bacteriology and epidemiology of Helicobacter pylori infection. UpToDate, last updated Jul 31, 2020. UpToDate 
  3. Helsedirektoratet. Antibiotika i primærhelsetjenesten. Sist oppdatert 16. november 2021. www.helsedirektoratet.no 
  4. Lamont JT. Indications and diagnostic tests for Helicobacter pylori infection in adults. UpToDate, last updated Apr 02, 2020. UpToDate 
  5. Moayyedi PM, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013. PubMed 
  6. Chey WD, Leontiadis GI, Howden CW, et al. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017 Feb;112(2):212-39. PubMed 
  7. Best LM, Takwoingi Y, Siddique S, et al. Non-invasive diagnostic tests for Helicobacter pylori infection. Cochrane Database Syst Rev. 2018;(3):CD012080. Cochrane (DOI) 
  8. Ford AC, Gurusamy KS, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016;4(4):CD003840. Published 2016 Apr 19. The Cochrane Library 
  9. Zhao B, Zhao J, Cheng WF, et al. Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up. J Clin Gastroenterol. 2014;48(3):241-247. PubMed 
  10. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61:646. Gut 
  11. Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol 2017; 112:988. PubMed 
  12. Kahrilas PJ. Medical management of gastroesophageal reflux disease in adults. UpToDate, last updated Nov 29, 2021. UpToDate 
  13. Lamont JT. Association between Helicobacter pylori infection and gastrointestinal malignancy. UpToDate, last updated Jan 25, 2022. UpToDate 
  14. Lee YC, Chiang TH, Chou CK, et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150(5):1113-1124.e5. PMID: 26836587 PubMed 
  15. Helsedirektoratet. Nasjonal faglig retningslinje for bruk av antibiotika i sykehus. Sist oppdatert 01.03.2022. www.helsedirektoratet.no 
  16. Ren Q, Yan X, Zhou Y, Li WX. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection. Cochrane Database of Syst Rev 2016, Issue 2. Art. No.: CD009477. DOI: 10.1002/14651858.CD009477.pub2. DOI 
  17. Szajewska H, Horvath A, Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 2010; 32: 1060-79. PubMed 
  18. Mišak Z, Hojsak I, Homan M. Review: Helicobacter pylori in pediatrics. Helicobacter. 2019;24 Suppl 1:e12639.